75% off all plans

Neuromuscular Junction

On this page

NMJ Structure - Synaptic Setup

Neuromuscular Junction Structure and Function

  • Presynaptic Terminal (Axon Bouton):
    • Synaptic vesicles (~50 nm diameter) with Acetylcholine (ACh).
    • Active zones: aligned with postsynaptic folds for ACh release.
    • Voltage-gated Ca²⁺ channels (VGCCs) trigger exocytosis.
  • Synaptic Cleft:
    • Gap: 20-50 nm wide.
    • Basal lamina: extracellular matrix containing Acetylcholinesterase (AChE).
  • Postsynaptic Membrane (Motor End Plate on Sarcolemma):
    • Junctional folds: ↑ surface area for nAChRs.
    • Nicotinic ACh Receptors (nAChRs): ligand-gated ion channels, concentrated at crests of folds.
    • Voltage-gated Na⁺ channels (VGSCs): located in depths of folds, crucial for action potential propagation.

⭐ Acetylcholinesterase (AChE) is concentrated in the basal lamina within the synaptic cleft, ensuring rapid termination of ACh action and preventing continuous muscle stimulation.

ACh Synthesis & Release - Pre-Synaptic Saga

  • Synthesis (Cytoplasm):

    • Choline + Acetyl CoA $\xrightarrow{Choline Acetyltransferase (ChAT)}$ Acetylcholine (ACh).
    • Rate-limiting step: Choline uptake by Na⁺-Choline Transporter 1 (CHT1). 📌 ChATs make ACh, CHT1 brings in Choline.
  • Storage (Synaptic Vesicles):

    • ACh actively concentrated into vesicles by Vesicular ACh Transporter (VAChT) using H⁺ gradient.
    • Each vesicle: ~5,000-10,000 ACh molecules (one quantum).
  • Release (Ca²⁺-Dependent Exocytosis):

    • SNARE proteins are targets for Botulinum & Tetanus toxins. ⚠️

⭐ ACh is released in discrete quanta. Each quantum (contents of one vesicle, ~5k-10k molecules) evokes a Miniature End-Plate Potential (MEPP).

Presynaptic events at the neuromuscular junction

Postsynaptic Events - Muscle's Spark

  • ACh diffuses across synaptic cleft; 2 ACh molecules bind to α-subunits of nicotinic ACh receptors (nAChR) on the motor end plate.
  • nAChR, a ligand-gated ion channel, opens:
    • Predominant Na+ influx, lesser K+ efflux.
  • Causes local, non-propagated depolarization: End Plate Potential (EPP).
    • EPP is graded; its amplitude depends on the amount of ACh released.
  • If EPP reaches threshold voltage (approx. -55mV), voltage-gated Na+ channels open.
  • This triggers a propagated muscle fiber Action Potential (AP).
  • AP initiates excitation-contraction coupling.
  • ACh action is terminated by Acetylcholinesterase (AChE) hydrolysis in the synaptic cleft. Neuromuscular junction excitation-contraction coupling

⭐ The End Plate Potential (EPP) is a graded, non-propagated potential; if it reaches threshold, it triggers a propagated muscle fiber action potential that leads to muscle contraction.

ACh Inactivation - Clearing the Cleft

  • Mechanism: Rapid enzymatic hydrolysis of acetylcholine (ACh).
  • Enzyme: Acetylcholinesterase (AChE).
    • Location: Synaptic cleft, anchored to basal lamina.
  • Reaction: ACh $\xrightarrow{AChE}$ Choline + Acetate.
  • Choline Fate: Actively reuptaken by presynaptic terminal (Na$^+$-Choline Transporter, ChT) for ACh resynthesis.
  • Significance:
    • Terminates ACh signal promptly.
    • Enables muscle fiber repolarization and relaxation.
    • Prevents continuous stimulation & receptor desensitization.

⭐ Rapid hydrolysis of ACh by acetylcholinesterase is essential for timely muscle relaxation and repolarization of the endplate.

NMJ Clinical Aspects - Meds & Mayhem

  • NMJ Blockers:
    • Depolarizing: Succinylcholine (fasciculations → paralysis).
    • Non-depolarizing: "-curoniums", "-curiums". Reversal: AChE inhibitors.
  • Toxins/Poisons:
    • Organophosphates: AChE inhibition. 📌 DUMBBELS (Diarrhea, Urination, Miosis, Bronchospasm, Bradycardia, Emesis, Lacrimation, Salivation). Antidote: Atropine, Pralidoxime.
    • Botulinum toxin: Blocks ACh release.
FeatureMyasthenia Gravis (MG)Lambert-Eaton (LEMS)
SitePostsynaptic (nAChR Ab)Presynaptic (VGCC Ab)
Effect↓ EPP, weakness worsens↓ ACh release, weakness improves
EMGDecremental responseIncremental response (>100%)
AssociationThymomaSmall Cell Lung Cancer

⭐ Myasthenia Gravis: Autoimmune, antibodies vs. postsynaptic nAChRs, ↓ EPP amplitude, muscle weakness that worsens with use.

High‑Yield Points - ⚡ Biggest Takeaways

  • Acetylcholine (ACh) is the primary neurotransmitter at the NMJ, binding to nicotinic ACh receptors (nAChR).
  • Acetylcholinesterase (AChE) in the synaptic cleft rapidly hydrolyzes ACh, terminating its action.
  • Presynaptic Ca2+ influx is essential for ACh vesicle release.
  • The End Plate Potential (EPP) is a graded potential; if threshold is met, it initiates a muscle action potential.
  • Myasthenia Gravis involves autoantibodies against nAChRs, reducing EPP amplitude and causing muscle weakness.
  • Lambert-Eaton Syndrome features impaired ACh release due to antibodies against presynaptic Ca2+ channels.
  • Botulinum toxin blocks ACh release; organophosphates and neostigmine inhibit AChE, prolonging ACh action.

Continue reading on OnCourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Neuromuscular Junction

Test your understanding with these related questions

Which of the following is a characteristic feature of myasthenia gravis?

1 of 5

Flashcards: Neuromuscular Junction

1/10

Stretch reflex:Activation of _____ motor neurons leads to direct contraction of the muscle

TAP TO REVEAL ANSWER

Stretch reflex:Activation of _____ motor neurons leads to direct contraction of the muscle

alpha

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE
Rezzy AI Tutor